Physician profile
Deborah Nio
NPI 1609877380
$15,780.07
in general payments reported to CMS, 2019-2025
53 companies · $2,664 in 2025
The $2,664 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,087 · 2020: $1,567 · 2021: $2,010 · 2022: $2,341 · 2023: $2,475 · 2024: $2,637 · 2025: $2,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,587 · Consulting Fee: $175 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,586.99 |
| Consulting Fee | $175.00 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,089.63 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,971.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,474.69 | 2019-2025 | |
| Amgen INC. | $1,320.04 | 2019-2025 | Prolia, Repatha, Otezla |
| Abbvie INC. | $1,180.87 | 2021-2025 | |
| Lilly USA, LLC | $1,150.87 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $951.36 | 2019-2025 | Jardiance |
| Abbott Laboratories | $868.88 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amarin Pharma, INC. | $657.20 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $405.64 | 2019-2024 | Xarelto |
| Glaxosmithkline, LLC. | $367.93 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $336.44 | 2019-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Biohaven Pharmaceutical Holding Company LTD. | $276.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $269.24 | 2019-2025 | Eliquis, Camzyos |
| Phathom Pharmaceuticals, INC. | $211.88 | 2025 | Voquezna |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $188.25 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.92 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $170.94 | 2019-2021 | |
| Esperion Therapeutics, INC. | $170.77 | 2020-2024 | Nexletol |
| Allergan, INC. | $168.48 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $144.88 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $96.12 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $91.11 | 2019-2023 | |
| Atricure, INC. | $83.67 | 2024 | |
| Sanofi Pasteur INC. | $78.24 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $74.00 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $70.38 | 2024-2025 | Caplyta |
| Antares Pharma, INC. | $68.97 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Currax Pharmaceuticals LLC | $54.26 | 2020-2023 | Contrave, Onzetra Xsail |
| Otsuka America Pharmaceutical, INC. | $52.81 | 2022-2024 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $50.99 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $47.63 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $39.78 | 2023 | Keveyis |
| Exact Sciences Corporation | $38.89 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Actelion Pharmaceuticals US, INC. | $34.85 | 2025 | Opsumit, Uptravi |
| Genentech USA, INC. | $32.45 | 2019-2020 | |
| Astellas Pharma US INC | $31.65 | 2019-2020 | |
| Eisai INC. | $30.49 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $25.40 | 2020 | |
| Corium, LLC | $24.56 | 2022 | |
| Becton, Dickinson and Company | $23.73 | 2025 | Bd Max System, Bd Max Instrument |
| Lundbeck LLC | $22.66 | 2024 | Vyepti |
| Kyowa Kirin, INC. | $21.35 | 2023 | Crysvita |
| Bayer Healthcare Pharmaceuticals INC. | $20.23 | 2022 | |
| Seqirus USA INC | $16.56 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.18 | 2022 | |
| Ardelyx, INC. | $15.85 | 2024 | Ibsrela |
| Philips North America LLC | $15.59 | 2024 | (5050) Extended Holter |
| Depuy Synthes Sales INC. | $13.08 | 2019 | |
| Boston Scientific Corporation | $12.69 | 2023 | Wavewriter Alpha Prime 16 |
| Nalpropion Pharmaceuticals LLC | $12.23 | 2019 | |
| Circassia INC. | $10.91 | 2019 | |
| Organogenesis INC. | $3.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Nio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.